Trileptal- Oxcarbazepine is the U. S. Food and Drugs
Administration-FDA approved anti-epileptic medication designed,
developed, manufactured and distributed by the world renowned
pharmaceutical formulators in U.S. by an affiliate of Novartis
Group of Switzerland. The drug has been produced in Tablet forms
having different dose strengths like: 150mg, 300mg and 600mg as
well as in oral Suspension with dose strength of 300mg per 5ml.
The drug has been indicated for use as mono-therapy by itself or
can be taken with other medication for treating the partial
seizures in adults and children over 4 years of age having
epilepsy. The drug is also used as adjunctive therapy for
treating the partial seizures in children ages 2 years and more
with epilepsy.
Generic Name: Trileptal
Brand Name:Trileptal
The branded prescription medication Trileptal- Oxcarbazepine is
believed to help the patients reducing their partial seizure
episodes. This medication is not associated with certain
incommodious cosmetic side effects of other anti-epileptic
drugs-AEDs like: Weight gain or weight loss, changes in the
facial features and abnormal hair growth. This drug has been
available in the United States since February 2000 and has been
prescribed for more than 1,000,000 patients by now while the
medication is already in use in the other nations across the
world since 1990.
The patients taking other anti-epileptic drugs
as per are required to undergo regular blood tests for che3cking their
liver enzyme abnormalities but in case of Trileptal-Oxcarbazepine such routine monitoring is not at all
required. In case if the patient is found to be prone to
hyponatremia then only the doctor may keep the patient on
monitor for checking his sodium blood levels.
